Live feed
Filing
SC 13G/A
SC 13G/A0000053417-17-000006·Spyre Therapeutics, Inc.
Schedule 13G ownership disclosure
AEGLEA BIOTHERAPEUTICS INC
Security class unavailable · CUSIP: 00773J103
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,445,713
- Percent of class
- 10.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-17-000006
- Form type
- SC 13G/A
- Filer
- Spyre Therapeutics, Inc.
- CIK
- CIK 1636282
- Filed
- Feb 02, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership